SEC Filing Summary: Westwood Holdings Group Inc.
Business Context and Reporting Period
Filing Type: Form 13F Information Table
Company: Westwood Holdings Group Inc.
Reporting Period: Quarter ended December 31, 2020
Context: This filing discloses the equity and debt securities held by Westwood Holdings Group Inc. as a registered investment manager. The table lists individual holdings, including common stock, preferred stock, and corporate notes, along with voting authority and investment discretion.
Key Financial Metrics and Portfolio Composition
Portfolio Overview: The filing details a diversified portfolio of large-cap equities and corporate debt. Specific aggregate portfolio value, total revenue, profit, or cash flow for Westwood Holdings Group Inc. is not provided in this Form 13F; the document strictly lists holdings.
Top Equity Holdings (by Value):
- JPMorgan Chase & Co: $161,393,000 (1,270,108 shares)
- Bank of America Corp: $153,905,000 (5,077,703 shares)
- Apple Inc: $151,824,000 (1,144,201 shares)
- Microsoft Corp: $137,018,000 (616,033 shares)
- Home Depot Inc: $129,446,000 (487,334 shares)
- Johnson & Johnson: $118,309,000 (751,741 shares)
- Medtronic PLC: $102,698,000 (876,712 shares)
- Abbott Labs: $94,738,000 (865,259 shares)
- Activision Blizzard Inc: $85,748,000 (923,512 shares)
- CVS Health Corp: $87,707,000 (1,284,159 shares)
Notable Debt Holdings (Principal Amounts):
- Fortive Corp Note: $34,250,000
- Avaya Holdings Corp Note: $29,500,000
- OSI Systems Inc Note: $27,655,000
- FireEye Inc Notes: $46,210,000 (Combined)
- Exact Sciences Corp Notes: $20,063,000 (Combined)
Material Changes and Voting Authority
Voting Authority: Westwood Holdings Group Inc. reported "Sole" voting authority for the majority of equity positions. "Shared" voting authority was reported for select positions including Alphabet Inc., Amazon.com Inc., and Berkshire Hathaway Inc. "None" was reported for certain holdings, such as Aptose Biosciences Inc. and Bristol-Myers Squibb Co.
Investment Discretion: The manager reported "Discretionary" (DFND) authority for all listed securities.
Comparative Data: This filing does not contain comparative data from the prior quarter (September 30, 2020). Therefore, material changes in position size or new entries cannot be quantified from this document alone.
Guidance, Risks, and Contingencies
Management Commentary: Form 13F filings do not contain management commentary, forward-looking guidance, or strategic outlooks.
Risks and Contingencies: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the company's operations are disclosed in this format.
Key Facts for Investor Verification
- Concentration Risk: Verify the total portfolio value to assess the concentration of the top 10 holdings, which are heavily weighted toward financials (JPMorgan, Bank of America) and technology (Apple, Microsoft).
- Debt Exposure: Confirm the credit quality of significant corporate note holdings, particularly in the technology and healthcare sectors (e.g., Fortive, Avaya, Exact Sciences).
- Ownership Structure: Note the mix of Sole vs. Shared voting authority, which may indicate co-investment structures or fund-of-fund arrangements for specific tickers.
- Missing Data: Acknowledge that this document does not provide Westwood Holdings Group Inc.'s own financial health (revenue, debt, liquidity) or performance metrics.